Metaphore Biotechnologies
Cambridge
About Metaphore Biotechnologies
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Last round: Undisclosed (May 2023)
- Website: metaphorebio.com
- Phone: [email protected].
Industries & Categories
Biotechnology, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/metaphore-biotechnologies-27385 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.